Specialty Pharmaceutical

ProSolus Inc., a subsidiary of Canoa Inc., specializes in the formulation and development of advanced transdermal and topical drug delivery systems. With a focus on high-barrier-to-entry products for various therapeutic categories, including pain management and cardiovascular care, ProSolus leverages its state-of-the-art laboratory and manufacturing facility in Miami, Florida, to deliver innovative solutions tailored to client needs. Backed by a leadership team with over 65 years of collective experience, ProSolus is committed to optimizing delivery methods without relying on exotic permeation enhancers. The company's comprehensive approach encompasses the entire product lifecycle, from formulation through to clinical and packaging stages, ensuring a customized experience for partners in the pharmaceutical industry. Generated from the website

Llorens Pharmaceutical International Division is a leading contract manufacturing company based in Miami, FL, specializing in the production of liquid nutraceuticals and supplements. With over 50 years of industry experience, their state-of-the-art facility and skilled professionals ensure that every batch meets the highest quality standards. They offer a wide range of services, including formulation development, labeling design, sourcing of ingredients and packaging, manufacturing, testing, and fulfillment. Llorens Pharmaceutical works with national hospitals, pharmacies, and brands, providing OTC manufacturing solutions, as well as collaborating with nutraceutical companies to develop and manufacture their supplements. With their expertise in sales, branding, logistics, and marketing, they also offer additional services such as branding, marketing consulting, and Amazon FBA consulting.Generated from the website

Accu-Break Pharmaceuticals Inc. is a privately-held pharmaceutical company dedicated to enhancing the functionality of pharmaceutical tablets through its patented ACCU-BREAK family of technologies. These innovations allow for easy division into equal half, third, or quarter doses, addressing the challenges of dose flexibility for patients and healthcare providers alike. The company's approach not only aims to improve medication adherence, particularly for pediatric and geriatric patients, but also offers significant benefits in drug reformulation and product lifecycle management. With a strong leadership team and a commitment to safety and precision, Accu-Break is poised to revolutionize how medications are administered and customized for individual needs. Generated from the website